TRANSCAN-3: Sustained collaboration of national and regional programs in cancer research
ERA-NET TRANSCAN-3 (2021-2026) is an ERA-NET Cofund in translational cancer research and is the third TRANSCAN initiative in which FCT is a partner. This network now has 31 partners from 20 countries. This ERA-NET aims to coordinate national/regional funding programs in the area of translational cancer research. The specific challenge is to promote a transnational collaborative approach between scientific teams in challenging areas of translational cancer research.
This initiative will receive funding from Horizon 2020 under Grant Agreement No. 964264.
Updated on June 9, 2023